Erratum for the Clinical and Translational Medicine “Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/ FoxO pathway” by Liuyun Gong et al
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Lipids, and Metabolism · FOXO transcription factor regulation
Liuyun Gong, Hanmin Tang, Zhenzhen Luo, Xiao Sun, Xinyue Tan, Lina Xie, Yutiantian Lei, Mengjiao Cai, Chenchen He, Jinlu Ma, Suxia Han
Department of Oncology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shanxi 710061, P. R. China.
Following the publication of the original article,^1^ the authors identified minor errors in Figure 4A, where the images of some groups were incorrect. Because during image assembly, we took 3–5 pictures at random from different angles of each slide, we mistakenly used the pictures. In Figure 4A: An overlap between 20 μmol/L TAM (200x) and 30 μmol/L TAM (400x) groups, we found our mistakes and reassembled the images, we also corrected the images for each group, we want to make a published erratum. More importantly, we promise that the erratum has no impact on the conclusion and description of the article.
- Gong LY, Tang HM, Luo ZZ, et al. Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway. Clin Transl Med. 2020;10(1):137‐150. Article. https://doi.org/10.1002/ctm2.5.